Part 9: What PARP inhibitors mean for the future and what to look out for

Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK
Part 9: What PARP inhibitors mean for the future and what to look out for ( Prof Philip Cornford - Royal Liverpool University Hospital, Liverpool, UK )
5 Sep 2023

The case for investing in women's cancers in Asia Pacific

Dr Heather White - Executive Director, TogetHER for Health
The case for investing in women's cancers in Asia Pacific ( Dr Heather White - Executive Director, TogetHER for Health )
4 Sep 2023

Nigeria solidarity support fund and the annual youth engagement campaign on HPV

Dr Fejiro Chinye-Nwoko - CEO, Nigeria Solidarity Support Fund, Lagos, Nigeria
Nigeria solidarity support fund and the annual youth engagement campaign on HPV ( Dr Fejiro Chinye-Nwoko - CEO, Nigeria Solidarity Support Fund, Lagos, Nigeria )
25 Aug 2023

Psilocybin-assisted psychotherapy for cancer-related anxiety and depression

Dr Moran Amit - The University of Texas MD Anderson Cancer Center, Houston, USA
Psilocybin-assisted psychotherapy for cancer-related anxiety and depression ( Dr Moran Amit - The University of Texas MD Anderson Cancer Center, Houston, USA )
23 Aug 2023

AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours

Dr Linda Malkas - City of Hope, Duarte, USA
AOH1996 treatment targeting PCNA shows promise for reoccurring solid tumours ( Dr Linda Malkas - City of Hope, Duarte, USA )
8 Aug 2023

OncoAlert round up July 28th to August 3rd, 2023

Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
4 Aug 2023

Sudan: Conflict, cancer care, and ripple effects on the region

Dr Nazik Hammad - University of Toronto, Toronto, Canada
Sudan: Conflict, cancer care, and ripple effects on the region ( Dr Nazik Hammad - University of Toronto, Toronto, Canada )
19 Jul 2023

Geriatric oncology in resource-limited settings

Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico City, Mexico
Geriatric oncology in resource-limited settings ( Dr Enrique Soto Perez de Celis - National Institute of Medical Sciences, Mexico City, Mexico )
18 Jul 2023

Gynaecological cancer: New targets and immunotherapy developments

Dr Mark Shahin - Jefferson Health, Philadelphia, USA
Gynaecological cancer: New targets and immunotherapy developments ( Dr Mark Shahin - Jefferson Health, Philadelphia, USA )
7 Jul 2023

ASCO 2023: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2023: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
6 Jun 2023

Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer

Prof Matthew Powell - Washington University School of Medicine, Missouri, USA
Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer ( Prof Matthew Powell - Washington University School of Medicine, Missouri, USA )
6 Jun 2023

FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain
FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer ( Dr Ana Oaknin - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
5 Jun 2023